Corrigendum: The value of targeted CXCR4 18F-AlF-NOTA-pentixafor PET/CT for subtyping primary aldosteronism

Corrigendum: The value of targeted CXCR4 18F-AlF-NOTA-pentixafor PET/CT for subtyping primary aldosteronism

Saved in:

Bibliographic Details
Main Authors:	Yushi Peng, Fangansheng Chen, Rui Yao, Junping Lan, Yinuo Fu, Kaifeng Ye, Zhiqiang Wang, Qianxiu Zhao, Xiaowei Ji, Kang Xia, Guoqing Zhu, Kewen Zheng, Xuemei Gu, Kun Tang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-04-01
Series:	Frontiers in Endocrinology
Subjects:	primary aldosteronism CXCR4 18 F-pentixafor PET/CT subtyping treatment
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2025.1593408/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The value of targeted CXCR4 18F-AlF-NOTA-pentixafor PET/CT for subtyping primary aldosteronism
by: Yushi Peng, et al.
Published: (2025-02-01)

68Ga-Pentixafor PET/CT for the assessment of therapeutic outcomes following superselective adrenal arterial embolization in patients with primary aldosteronism
by: MengDan Li, et al.
Published: (2025-01-01)

The prognostic value of CXCR4 PET/CT imaging in unilateral primary aldosteronism patients after adrenalectomy
by: Shuai Shao, et al.
Published: (2025-04-01)

Reduced splenic uptake of [68Ga]Ga-Pentixafor following first-line chemotherapy is associated with poor prognosis in patients with newly diagnosed multiple myeloma
by: Qingqing Pan, et al.
Published: (2025-06-01)

Clinical diagnosis and treatment of a patient with hypertension, hypokalemia, and bilateral adrenal adenomas
by: Tingting Zhang, et al.
Published: (2025-05-01)

The association between aldosterone and lipid profiles in patients with primary aldosteronism
by: Ning-Peng Liang, et al.
Published: (2025-03-01)

Establishment and evaluation of a patient-derived organoids-based xenograft model of primary aldosteronism using [18F]AlF-NOTA-pentixather PET/CT: bridging preclinical and clinical imaging
by: Xuezhou Zhang, et al.
Published: (2025-08-01)

Development and validation of prediction models for special subtype of primary aldosteronism: patients with negative adrenal CT imaging
by: Hong Zhao, et al.
Published: (2025-07-01)

CXCR4 and CXCR6 dually limit T cell entry into the polyomavirus-infected brain
by: Kalynn M. Alexander, et al.
Published: (2025-06-01)

Towards a General Method for Using Cyclotron-Produced Ga68 to Manufacture Clinical and Research Ga68 Tracers
by: Ivan E. Wang, et al.
Published: (2024-11-01)

Effect of Age on Aldosterone–Renin Ratio in Screening Primary Aldosteronism
by: Ning Peng, et al.
Published: (2025-03-01)

Inhibition of the chemokine receptors CXCR1 and CXCR2 synergizes with docetaxel for effective tumor control and remodeling of the immune microenvironment of HPV-negative head and neck cancer models
by: Lucas A. Horn, et al.
Published: (2024-12-01)

Pathology and gene mutations of aldosterone-producing lesions
by: Koshiro Nishimoto, et al.
Published: (2023-12-01)

Adipose Composition Before and After Primary Aldosteronism Treatment Depends on Primary Aldosteronism Subtypes and Plasma Aldosterone Concentration Before the Treatment
by: Eriko Nakano, et al.
Published: (2025-07-01)

Effect of plasma aldosterone concentration on serum uric acid metabolism
by: WEI Yushuang, et al.
Published: (2025-02-01)

Renal Dysfunction in Primary Aldosteronism: How, When, and Who?
by: Michael Kitlinski, et al.
Published: (2025-01-01)

A clinical decision model for failed adrenal vein sampling in primary aldosteronism
by: Sophie N. M. ter Haar, et al.
Published: (2025-01-01)

Elderly men are underscreened for primary aldosteronism even in Hypertension Excellence Centre
by: Avital Angel Korman, et al.
Published: (2024-12-01)

CXCR3 inhibitors for therapeutic interventions: current status and perspectives
by: Rongrong Huo, et al.
Published: (2025-07-01)

Diagnostic uncertainty in primary aldosteronism
by: Marković Bojan, et al.
Published: (2024-01-01)

Duration of rheumatoid arthritis changes blood levels of angiotensin and aldosterone
by: Boris A. Rebrov, et al.
Published: (2023-12-01)

Clinical value of sublingual microcirculatory dysfunction for screening for primary aldosteronism in hypertensive patients
by: Wuhao Wang, et al.
Published: (2025-07-01)

Screening for primary aldosteronism in 1,181 Swedish primary care patients with hypertension
by: Nikita Makhnov, et al.
Published: (2025-04-01)

Occurrence of Metabolic Disorders in Bilateral Primary Aldosteronism Compared to Unilateral Primary Aldosteronism
by: Chiara Grasselli, et al.
Published: (2025-02-01)

Intratumoural aldosterone and CYP11B2 expression levels among different genotypes of aldosterone producing tumours
by: Tobias Åkerström, et al.
Published: (2025-06-01)

Advances in the biochemical diagnostics of primary aldosteronism: from immunoassays to steroidomics and proteomics
by: Alicja Szatko, et al.
Published: (2025-04-01)

Blood aldosterone level in various types of atrial fibrillation
by: N. T. Vatutin, et al.
Published: (2016-02-01)

The Effects of Aldosterone on Hypertension-Associated Kidney Injury in a Tg-hAS Mouse Model
by: Huiying Gu, et al.
Published: (2024-12-01)

Comparison between screening for primary aldosteronism with and without drug adjustment
by: Yanlong Hua, et al.
Published: (2024-12-01)

The CXCL12/CXCR4 Axis: An Emerging Therapeutic Target for Chronic Pain
by: Chen Z, et al.
Published: (2025-05-01)

Histopathological spectrum of common aldosterone-driver gene mutations in aldosterone-producing adenomas
by: Fatin Athirah Pauzi, et al.
Published: (2025-06-01)

The state of renin-aldosterone system in patients with resistant arterial hypertension
by: О. H. Оbertynska
Published: (2019-06-01)

Unsupervised Feature Selection via a Dual-Graph Autoencoder with <inline-formula><math display="inline"><semantics><mrow><msub><mi mathvariant="bold-script">l</mi><mrow><mn mathvariant="bold">2</mn><mo mathvariant="bold">,</mo><mn mathvariant="bold">1</mn><mo mathvariant="bold">/</mo><mn mathvariant="bold">2</mn></mrow></msub></mrow></semantics></math></inline-formula>-Norm for [<sup>68</sup>Ga]Ga-Pentixafor PET Imaging of Glioma
by: Zhichao Song, et al.
Published: (2025-05-01)

Plasma Aldosterone Elevation in Hypertensive Patients and Association with Urinary Stone Formation: A Large-Scale Population Study from Northwest China
by: Song S, et al.
Published: (2025-05-01)

Mechanism underlying the involvement of CXCR4/CXCL12 in diabetic wound healing and prospects for responsive hydrogel-loaded CXCR4 formulations
by: Lingli Wang, et al.
Published: (2025-04-01)

Shifting paradigms in primary aldosteronism: reconsideration of screening strategy via integrating pathophysiological insights
by: Takumi Kitamoto, et al.
Published: (2025-01-01)

Cross-sectional association between plasma aldosterone concentration and cognitive performance by mini-mental state examination in community dwellers
by: Aketilieke Nusufujiang, et al.
Published: (2025-02-01)

Heterogeneous phenotype of a Chinese Familial WHIM syndrome with CXCR4V340fs gain-of-function mutation
by: Yu Huang, et al.
Published: (2024-11-01)

Correction: Mechanism underlying the involvement of CXCR4/CXCL12 in diabetic wound healing and prospects for responsive hydrogel-loaded CXCR4 formulations
by: Lingli Wang, et al.
Published: (2025-07-01)

Loss of CXCR5 expression and monocyte epithelial–mesenchymal transition are blood‐borne signatures of sterile granulomatous diseases
by: Yuwei Hao, et al.
Published: (2025-01-01)